Announced Fri, 29 May · 12:35 IST

Audited Financial results for the quarter and year ended on March 31, 2026

Pat Growth 25pctEbitda Margin ExpansionResults View source PDF

RELCHEMQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.6%1-day move
₹123.00
prior close
₹122.51
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.1+1.2-1.6-1.5-2.4+0.2+0.8+0.7+10.6+10.6
Up moveDown movePending
AI summary

Reliance Chemotex Industries reported audited results for FY26 with net profit of Rs 526.15 Lacs, up 30% from Rs 404.52 Lacs in FY25, driven by lower tax expenses and improved other income. Revenue from operations grew marginally by 1% to Rs 36,200.58 Lacs (FY25: Rs 35,859.78 Lacs). Finance costs increased to Rs 2,490.48 Lacs from Rs 2,411.03 Lacs. The company reported PAT growth of ~30% for the year, though Q4 net profit of Rs 174.59 Lacs was slightly lower than Q4 FY25's Rs 184.02 Lacs. The Board recommended a final dividend of Rs 0.50 per share (5%). Statutory auditors P K MB & Co issued an unmodified opinion, indicating clean financials.

Likely market impact

The 30% PAT growth and improved EBITDA margin are positive signals despite modest revenue growth. Shareholders receive a dividend payout of Rs 37.72 Lacs. The company shows healthy profitability improvement year-on-year.